5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results

Clinical trial NCT02355574 · TERMINATED

Trial details

NCT number: NCT02355574
Sponsor: Castle Biosciences Incorporated
Status: TERMINATED
Study type: OBSERVATIONAL

Cutaneous Melanoma

Start date: 2014-06-01
Primary completion: 2021-02-01
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.